Skip to main content

Neuralink competitor Paradromics gets one step closer to FDA approval for its brain implant

Paradromics has received the Breakthrough Device designation from the FDA
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.